KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vertex Pharmaceuticals (VRTX) Income from Continuing Operations (2016 - 2025)

Vertex Pharmaceuticals has reported Income from Continuing Operations over the past 17 years, most recently at 1191100000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 1191100000.0 for Q4 2025, up 30.46% from a year ago — trailing twelve months through Dec 2025 was 3953200000.0 (up 838.09% YoY), and the annual figure for FY2025 was 3953200000.0, up 838.09%.
  • Income from Continuing Operations for Q4 2025 was 1191100000.0 at Vertex Pharmaceuticals, up from 1082900000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for VRTX hit a ceiling of 1191100000.0 in Q4 2025 and a floor of 3593600000.0 in Q2 2024.
  • Median Income from Continuing Operations over the past 5 years was 882450000.0 (2021), compared with a mean of 635065000.0.
  • Biggest five-year swings in Income from Continuing Operations: soared 1109.7% in 2022 and later plummeted 492.44% in 2024.
  • Vertex Pharmaceuticals' Income from Continuing Operations stood at 770100000.0 in 2021, then grew by 6.34% to 818900000.0 in 2022, then rose by 18.31% to 968800000.0 in 2023, then fell by 5.76% to 913000000.0 in 2024, then surged by 30.46% to 1191100000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 1191100000.0 (Q4 2025), 1082900000.0 (Q3 2025), and 1032900000.0 (Q2 2025) per Business Quant data.